-
Company Profile
AnaptysBio Inc – Company Profile
AnaptysBio Inc (AnaptysBio) is a clinical-stage biotechnology company that focuses on the development of antibody candidates for the treatment of atopic dermatitis, ovarian cancer, lung cancer, asthma, psoriasis, inflammation and other autoimmune indications. The company develops its product candidates through its proprietary antibody discovery technology platform that is based on somatic hypermutation (SHM). The company has various product candidates under development for the treatment of moderate-to-severe adult atopic dermatitis, asthma, generalized pustular psoriasis and palmo-plantar pustular psoriasis, and human autoimmune...
Add to Basket -
Product Insights
Quarterly Milk pricing trends in the United Kingdom
Consumers' preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices. GlobalData's new report titled "Quarterly Milk pricing trends in the United Kingdom" serves as a crucial resource for...
-
Sector Analysis
Multiple Sclerosis Market Size, Drug Analysis, Epidemiology, Disease Management, Pipeline Assessment, Unmet Needs and Forecast to 2030
Multiple Sclerosis Market Report Overview The drug sales for MS across the 7MM was $18.9 billion in 2020 and will achieve a CAGR of more than 4% during 2020-2030. An increase in the treatment rate of progressive MS, which will mitigate the effect of generic erosion of the top-selling agents will drive market growth during the forecast period. Multiple Sclerosis Market Outlook, 2020-2030 ($ Billion) Buy the Full Report to Gain More Information on the Multiple Sclerosis Market Forecast Download...
-
Sector Analysis
Oral Hygiene Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Oral Hygiene Market Overview The oral hygiene market size was valued at $44.7 billion in 2022. Consumers’ growing health concerns and increasing awareness about oral hygiene are pushing the demand for oral hygiene products, globally. Moreover, the essential role of oral hygiene products (such as toothpaste and toothbrushes) in consumers’ daily lives is also benefiting sector sales. Consumers are also seeking innovations and improvements in sector products as they pursue better oral health.  Additionally, growing awareness among consumers about the...
-
Sector Analysis
Diabetic Neuropathic Pain Market Size, Drug Analysis, Epidemiology, Disease Management, Pipeline Assessment, Unmet Needs and Forecast 2031
Diabetic Neuropathic Pain Market Report Overview The DNP market size across the 7MM was valued at $1.7 billion in 2021 and will achieve a CAGR of more than 2% during 2021-2031. The large prevalent population of patients with DNP, the high cost of drugs, and the number of drugs marketed exclusively in the US compared to other countries in the 7MM will drive market growth during the forecast period. Diabetic Neuropathic Pain Market Outlook, 2021-2031 ($ Billion) Buy the Full...
-
Sector Analysis
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Report Overview Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. Â Influenza infection is normally self-limiting. Symptoms generally last for one to two weeks, but most people infected with influenza do not need or seek medical treatment. The Seasonal Influenza Therapeutics (SIT) marketed and pipeline drugs market research report provides a data-driven overview...
-
Sector Analysis
Pulmonary Arterial Hypertension Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
Pulmonary Arterial Hypertension Market Overview The Pulmonary Arterial Hypertension (PAH) market size across the 7MM was valued at $4.6 billion in 2019 and is forecast to grow at a CAGR of more than 4% during 2019-2029. Pulmonary Arterial Hypertension Market Outlook To gain more information on the Pulmonary Arterial Hypertension market forecast, download a free report sample The Pulmonary Arterial Hypertension market research report provides an overview of PAH, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and disease management. Market Size (2019)...
-
Sector Analysis
Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Sweden Healthcare Market Report Overview The Sweden pharmaceutical market size was SEK 53.4 billion ($6.2 billion) in 2021. Likewise, the Swedish medical devices market size was $2.1 billion in 2021 and will achieve a CAGR of more than 3% during 2022-2027. The growing aging population; lifestyle-related disease conditions such as diabetes and obesity; and increased prevalence of chronic diseases such as cardiovascular conditions, stroke, and cancer will drive the pharmaceutical market growth. The Sweden healthcare market research report is an...
-
Sector Analysis
Argentina Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Argentina Healthcare (Pharma and Medical Devices) Market Report Overview The Argentina pharmaceutical market size was $4.7 billion in 2020 and is expected to decline at a negative CAGR of more than 8% during 2020-2025. The medical devices market size in Argentina was valued at $5.8 billion in 2021 and is expected to achieve a CAGR of more than 1% during 2022-2027. The Argentine Ministry of Health (MinSalud) approved the “Plan for the Development of Pharmaceutical Services Based on Primary Health...